Company Short-Term Debts: Bio-Rad Laboratories Inc (BIO)

Public company logo of Bio-Rad Laboratories (BIO)

Bio-Rad Laboratories (BIO) maintains a strong position in the production of diagnostic equipment despite risks associated with the reduction of venture capital. Short-term loan capital dynamics demonstrate stability, with the latest value recorded as 0.35. The company relies on loyal clients from the scientific and medical sectors, providing critical quality control systems without which clinics would lose their certification.

BIO Bio-Rad Laboratories, Inc. Company Short-Term Debt (07/04/2022 - 10/28/2026)

Summary analytical data breakdowns for Bio-Rad Corp (BIO)

- price and consensus price forecast:
Price Chart Bio-Rad|BIO - Broker Consensus Forecast
- market capitalization data:
Market Capitalization Bio-Rad Laboratories, Inc.|BIO - Enterprise Value
- book capitalization data:
Net Assets per Single Share Bio-Rad|BIO - Company Book Value|Market Cap to Net Assets Ratio bio-rad.com|BIO - Company Assets
- debt and liquidity data:
Debt to Equity Bio-Rad Laboratories|BIO - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Bio-Rad Laboratories|BIO - Company Total Debt Obligations|Debt to Book Capitalization Ratio Bio-Rad Laboratories, Inc.|BIO - Long-Term Debt Volume|Company Short-Term Debts Bio-Rad
Fundamental company valuation:Bio-Rad BIO
Product sample of Bio-Rad Corp

The selection of the issuer is based on an analysis of solvency and a comparison of liabilities against liquid assets. This indicator measures the total amount of loans maturing within twelve months, which, combined with the global sales diversification and logistics optimization of Bio-Rad Laboratories (BIO), allows for the assessment of cash gap risks by tracking credit obligations with a maturity of up to one year.

Competitors of Bio-Rad Laboratories (BIO)

Agilent (A) - Company Short-Term Debt|DGX - Company Short-Term Indebtedness|ILMN: Company Short-Term Debts|EXAS (Exact Sciences Inc.) - Company Short-Term Debts|Company Short-Term Debt Revvity, Inc.|Company Short-Term Debt anbio.com (NNNN)|Sotera Health - Company Current Liabilities|Short-Term Debt QDEL (Quidel Corporation)|Company Short-Term Debt OPK|Short-Term Debt Volume CareDx CDNA|Company Short-Term Debts MRVI (Maravai LifeSciences)|FLGT: Short-Term Debt Volume|Standard BioTools - Company Short-Term Debt|Cytek Biosciences Inc (CTKB) - Short-Term Debt Volume|Company Short-Term Debts OraSure Technologies Inc|Company Short-Term Debt Exagen Diagnostics|MDXH (MDxHealth SA) - Company Short-Term Debts|Short-Term Debt Volume LUCD (luciddx.com)|PRE: Company Short-Term Debt|IMDX - Short-Term Debt|Company Current Liabilities TRIB|PRPH: Short-Term Indebtedness|Company Short-Term Debt Ainos, Inc. AIMD|codiagnostics.com (CODX) - Company Short-Term Loans and Borrowings|HSCS (HeartSciences) - Company Short-Term Debts|Company Short-Term Debts Biomerica Inc.|Company Short-Term Debts Cardio Diagnostics CDIO|Company Short-Term Indebtedness Virax Biolabs Corp VRAX|Company Current Liabilities Bluejay Diagnostics|aspirawh.com - Company Short-Term Loans and Borrowings|AXDX - Company Short-Term Debt|CNTG - Company Short-Term Debt|ENZ: Company Short-Term Debts|Fresh2 Group (FRES) - Company Short-Term Debts|Company Short-Term Debts Genetic Technologies Ltd|Company Short-Term Debt ME|Psychemedics Corporation - Company Short-Term Debt